Isomorphic Labs Enters Strategic Research Collaboration with MSD
Isomorphic Labs has entered a strategic research collaboration with MSD, combining its AI approach to drug discovery with MSD's proprietary data and discovery experience. The partners aim to advance therapeutic candidates for patients with unmet needs. Financial terms and the number of targets have not been disclosed.